Explore evidence

6.5 %Among offspring of non-diabetic parents in Cameroon, 6.5% were glucose intolerant, all with impaired glucose tolerance.

Camerounglucose intolerancepublished 2000Diabetes careeurope_pmcdocument of 2 observationsDOI 10.2337/diacare.23.12.1761

10.1 %The intervention induced a reduction in HbA1c from 10.1% to 6.7%.

Cameroundiabète de type 2published 2019Diabetes research and clinical practiceeurope_pmcdocument of 4 observations

3 specimensPhylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 3 were group O.

CamerounVIH/sidapublished 2000AIDS Research and Human RetrovirusesOpenAlexdocument of 7 observations

5 %Le paludisme est responsable de 5 % des décès chez les femmes enceintes au Cameroun selon les rapports d’activités du PNLP en 2006.

Camerounpaludismeobserved 2006HAL · Unilimdocument of 98 observations

8 patientsAmong 24 genetically tested Cameroonian patients with congenital adrenal hyperplasia, CYP21A2 mutation was found in 8 patients.

Camerouncongenital adrenal hyperplasiapublished 2022Journal of pediatric endocrinology & metabolism : JPEMeurope_pmcdocument of 6 observations

5 %The prevalence of the 77I substitution in protease sequences was 5% (3/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublished 2011AIDS Research and Human RetrovirusesOpenAlexdocument of 24 observations

1.9 %The vertical transmission rate was 1.9% (6/321) among infants born to mothers who commenced HAART during pregnancy.

CamerounVIH/sidaobserved November 2007 to October 2010published 2019Paediatrics and international child healthPubMeddocument of 7 observations

3 %Old World monkeys showed infrequent seroreactivity (3%) to HBoV.

CamerounHBoVpublished 2010Journal of VirologyOpenAlexdocument of 10 observations

30 %Prevalence of obesity was more than 30% in girls in Nauru, the Cook Islands, and Palau in 2016.

Camerounobésitéobserved 2016published 2017Lancet (London, England)europe_pmcdocument of 12 observations

5 %Coronary heart disease may affect 5% to 8% of type 2 diabetic patients in sub-Saharan Africa.

Camerouncoronary heart disease · diabète de type 2published 2005Circulationeurope_pmcdocument of 5 observationsDOI 10.1161/circulationaha.105.544312

12.5 %Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 12.5% had resistance to nucleoside reverse transcriptase inhibitors (NRTIs).

CamerounVIH/sidapublished 2006Emerging infectious diseasesOpenAlexdocument of 4 observationsDOI 10.3201/eid1206.050860

16 days_per_patient_per_yearPatients in Eurasia experienced an annual number of diabetes-related inpatient days of 16.0 days per patient (mean±SD: 16.0±30.0).

Cameroundiabète de type 2observed 2011-2012published 2017BMJ open diabetes research & careeurope_pmc

4 %In Cameroon, 4 out of 90 participants had severe eGFR impairment (<30 mL/min), representing 4%.

Camerounmaladie rénale chroniqueHAL · Unilimdocument of 205 observations

11.7 mm HgSystolic blood pressure dropped by 11.7 mm Hg between baseline and final visits.

Camerounhypertension artériellepublished 2009Journal of clinical hypertension (Greenwich, Conn.)europe_pmcdocument of 5 observationsDOI 10.1111/j.1751-7176.2009.00165.x

1,505,900,000 casesThe most prevalent neurological disorder in 2015 was tension-type headache, with 1505.9 million cases.

Camerountension-type headacheobserved 2015published 2017The Lancet. Neurologyeurope_pmcdocument of 10 observations

50.7 %The prevalence of undiagnosed diabetes in the Africa Region (AFR) was 50.7%.

Camerounundiagnosed diabetespublished 2014Diabetes research and clinical practiceeurope_pmcdocument of 14 observations

75 %Le PSNLP 2014-2018 visait à réduire de 75 % la mortalité et la morbidité dues au paludisme par rapport à la situation de 2000 d’ici 2018.

Camerounpaludismeobserved 2018HAL · Unilimdocument of 98 observations

89 %Among 36 HIV-1 infected blood donors in Cameroon, 32 (89%) responded to at least one peptide pool in the IFNγ ELISPOT assay.

CamerounVIH/sidapublished 2009RetrovirologyOpenAlexdocument of 6 observationsDOI 10.1186/1742-4690-6-s3-p273

21 patientsA cohort of patients of sub-Saharan African origin included 21 patients with type 1 diabetes.

Cameroundiabète de type 1published 2004Diabeteseurope_pmcdocument of 8 observationsDOI 10.2337/diabetes.53.3.645

56.6 %Hypertension prevalence among Bamileke in Cameroon was 56.6% [95% CI 49.4–63.8].

Camerounhypertension artériellepublished 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165

4.3 %Pretreatment HIV drug resistance (PDR) prevalence among ART initiators in rural areas of Cameroon was 4.3% (95% CI 1.2%–14.3%).

CamerounVIH/sidaobserved 2015published 2018Journal of Antimicrobial ChemotherapyOpenAlexdocument of 12 observationsDOI 10.1093/jac/dky221

2.6 odds_ratioThe summary odds ratio between non-autoimmune diabetes and Parvovirus B19 infection risk was 2.6 (95% CI: 0.7–9.1) based on one study.

Camerounnon-autoimmune diabetes mellitus · parvovirus B19published 2021Scientific reportseurope_pmcdocument of 11 observationsDOI 10.1038/s41598-021-88598-6

56 patientsA total of 56 diabetic patients with serious hand or foot infections were included in the final analyses.

Cameroundiabète (non précisé) · hand or foot infectionsobserved 2006–2008published 2010The Journal of foot and ankle surgery : official publication of the American College of Foeurope_pmcdocument of 12 observations

24 %161 (24%) of samples yielded a detectable viral load (>400 copies/mL).

CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

1,500,000 casesIn 2017, there were 1.5 million incident cases of tracheal, bronchus, and lung cancer in men.

Camerountracheal, bronchus, and lung cancerobserved 2017published 2019JAMA oncologyeurope_pmcdocument of 25 observationsDOI 10.1001/jamaoncol.2019.2996